clofibrate and etofibrate

clofibrate has been researched along with etofibrate in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	42 (91.30)	18.7374
1990's	3 (6.52)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (2.17)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Aragones, MD; Armijo, M; Catalán, RE; Martinez, AM; Priego, JG	1
Catalan, RE; Maroto, ML; Piña, M; Priego, JG	2
Gustafson, A	1
Loewer, H; Mertz, DP; Suermann, I	1
Pfeiffer, M; Tilsner, V	1
Rahlfs, VW; Safer, A; Zimmermann, H	1
Kłosiewicz-Latoszek, L; Szostak, WB	1
Betz, E; Quack, G	1
Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A	1
Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM	1
Castro, M; Gómez-Coronado, D; Herrera, E; Lasunción, MA; Martín, A; Quack, G	1
Palmer, RH	1
Caslake, MJ; Cruickshank, A; Demant, T; Kilday, C; Packard, CJ; Series, JJ; Shepherd, J	1
Armijo Castro, F; Gutierrez Fuentes, JA; Pire Solis, I; Vazquez Lopez, F	1
Holm, E; Schatton, W	1
Betz, E; Hämmerle, H	1
Altmayer, P; Garrett, ER	2
Chasseaud, LF; Schatton, W; Taylor, T; Waller, AR	1
Bardosi, A; Goebel, HH; Scheidt, P	1
Goebel, KM; Hausmann, L; Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Bochenek, W; Słowińska, R; Unlot, J	1
Santafé Oroz, J; Segarra Domènech, J	1
Díaz Méndez, M; Priego, JG	1
Hoppe, HJ; Johnson, KI; Schatton, W	1
Degenring, FH; Hotz, W; Schatton, W	1
Schatton, W	1
Kaffarnik, H; Schneider, J; Schubotz, R; Zöfel, P	1
Lang, PD; Vollmar, J	1
Djaja, S; Machalke, K; Richter, E	1
Armijo, M; Ortega, MP; Priego, JG; Sunkel, C	1
Altomonte, L; De Cunto, F; Greco, AV; Mingrone, G; Negrini, A	1
Gardner, MR; Garrett, ER	1
von Bock und Polach, U	1
Udelhoven, P	1
Ewert, M; Nachev, P; Oelschläger, H; Rothley, D	1
Göhmann, E; Mertz, DP; Suermann, I	1
Altomonte, L; Ghirlanda, G; Greco, AV; Manna, R; Mingrone, G; Pala, MA; Rebuzzi, A	1
Steger, W	1
Füsgen, I; Summa, JD	1
Calder, D; Luley, C; Scheffler, W; Schilling, A; Schwartzkopff, W	1
Mertz, DP	1

Reviews

2 review(s) available for clofibrate and etofibrate

Article	Year
Effects of fibric acid derivatives on biliary lipid composition. The American journal of medicine, 1987, Nov-27, Volume: 83, Issue:5B Topics: Bezafibrate; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Propionates; Random Allocation	1987
[Pharmacologic therapy of atherosclerosis (I). Current possibilities]. Medicina clinica, 1983, Nov-26, Volume: 81, Issue:17 Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol	1983

Trials

8 trial(s) available for clofibrate and etofibrate

Article	Year
[Etofibrate and clofibrate in double blind study]. Deutsche medizinische Wochenschrift (1946), 1976, Jul-30, Volume: 101, Issue:31 Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Nicotinic Acids; Placebos	1976
Effects of fibric acid derivatives on biliary lipid composition. The American journal of medicine, 1987, Nov-27, Volume: 83, Issue:5B Topics: Bezafibrate; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Propionates; Random Allocation	1987
[Study of the antilipemic effect of etofibrate (Lipo-Merz)]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Apr-25, Volume: 38, Issue:17 Topics: Adult; Aged; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged	1983
[Pharmacology and mechanism of action of etofibrate]. Die Medizinische Welt, 1982, Sep-24, Volume: 33, Issue:38 Topics: Animals; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids	1982
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias]. Therapie der Gegenwart, 1982, Volume: 121, Issue:5 Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate	1982
[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate]. La Clinica terapeutica, 1981, Jan-15, Volume: 96, Issue:1 Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged	1981
[Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug]. Fortschritte der Medizin, 1980, May-15, Volume: 98, Issue:18 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Niacin; Nicotinic Acids; Triglycerides	1980
[An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations]. Medizinische Klinik, 1980, Nov-07, Volume: 75, Issue:23 Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1980

Other Studies

37 other study(ies) available for clofibrate and etofibrate

Article	Year
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats. General pharmacology, 1979, Volume: 10, Issue:6 Topics: Adipose Tissue; Animals; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Insulin; Liver; Male; Nicotinic Acids; Protein Binding; Protein Kinases; Rats	1979
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats. General pharmacology, 1979, Volume: 10, Issue:3 Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Lipid Metabolism; Lipids; Lipoproteins; Liver; Male; Nicotinic Acids; Phospholipids; Rats	1979
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats. General pharmacology, 1979, Volume: 10, Issue:4 Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Nicotinic Acids; Rats; Triglycerides	1979
Treatment of hyperlipoproteinemia type II with etofibrate. International journal of clinical pharmacology and biopharmacy, 1979, Volume: 17, Issue:12 Topics: Body Weight; Cholesterol; Clofibrate; Clofibric Acid; Glucose Tolerance Test; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Liver Function Tests; Male; Middle Aged; Nicotinic Acids; Time Factors	1979
[The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)]. Medizinische Klinik, 1979, Dec-21, Volume: 74, Issue:51-52 Topics: Adult; Aged; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged	1979
[Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)]. Medizinische Klinik, 1978, Jan-13, Volume: 73, Issue:2 Topics: Blood Viscosity; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides	1978
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. European journal of clinical pharmacology, 1991, Volume: 40, Issue:1 Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol	1991
[Lipid therapy with etofibrate. Reduction of multiple risk factors with an active substance. Report of an international seminar. 8-11 November 1989, Houston, Texas]. Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis, 1990, Volume: 85 Topics: Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents	1990
Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis. VASA. Zeitschrift fur Gefasskrankheiten, 1990, Volume: 19, Issue:2 Topics: Animals; Arteriosclerosis; Clofibrate; Clofibric Acid; Disease Models, Animal; Hypolipidemic Agents; Rabbits	1990
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. Fortschritte der Medizin, 1989, Jul-10, Volume: 107, Issue:20 Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Triglycerides	1989
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes. Immunopharmacology, 1985, Volume: 9, Issue:2 Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Niacin; Thiophenes; Ticlopidine	1985
Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism. Biochimica et biophysica acta, 1988, Nov-04, Volume: 963, Issue:1 Topics: Adipose Tissue; Animals; Clofibrate; Clofibric Acid; Fatty Acids, Nonesterified; Glycerol; Lipolysis; Lipoproteins, VLDL; Liver; Male; Palmitic Acid; Palmitic Acids; Rats; Rats, Inbred Strains; Triglycerides	1988
Influence of etofibrate on low density lipoprotein metabolism. Atherosclerosis, 1988, Volume: 69, Issue:2-3 Topics: Adult; Anticholesteremic Agents; Clofibrate; Clofibric Acid; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged	1988
Concentration of clofibric acid in blood after the administration of delayed-release form of etofibrate. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:1 Topics: Adult; Biotransformation; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Humans; Kinetics; Male; Tablets, Enteric-Coated	1987
[Etofibrate in severe diet-refractory cases of hyperlipoproteinemia]. Fortschritte der Medizin, 1986, Apr-03, Volume: 104, Issue:13 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Dietary Fats; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides	1986
Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures. Arzneimittel-Forschung, 1986, Volume: 36, Issue:1 Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Carotid Arteries; Cell Division; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Clofibrate; Clofibric Acid; Clone Cells; Electric Stimulation; Fibroblasts; Lipoproteins, HDL; Male; Muscle, Smooth, Vascular; Rabbits; Triglycerides	1986
Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs. Journal of pharmaceutical sciences, 1985, Volume: 74, Issue:3 Topics: Animals; Clofibrate; Clofibric Acid; Dogs; Esters; Half-Life; Hypolipidemic Agents; Injections, Intravenous; Kinetics; Male; Niacin; Solubility; Solvents; Time Factors	1985
Bioavailability studies of etofibrate in rhesus monkeys. Arzneimittel-Forschung, 1985, Volume: 35, Issue:2 Topics: Animals; Biological Availability; Clofibrate; Clofibric Acid; Drug Interactions; Female; Half-Life; Hypolipidemic Agents; Intestinal Absorption; Macaca mulatta; Niacin; Time Factors	1985
Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report. Acta neuropathologica, 1985, Volume: 68, Issue:2 Topics: Aged; Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents; Kearns-Sayre Syndrome; Male; Microscopy, Electron; Mitochondria, Muscle; Muscles; Muscular Diseases	1985
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations. Artery, 1980, Volume: 8, Issue:6 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransferase; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Triglycerides; Uric Acid	1980
[Pharmacologic therapy of arteriosclerosis: current possibilities]. Medicina clinica, 1984, Oct-06, Volume: 83, Issue:10 Topics: Anticholesteremic Agents; Arteriosclerosis; Clofibrate; Clofibric Acid; Humans	1984
Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulation. Arzneimittel-Forschung, 1984, Volume: 34, Issue:12 Topics: Adult; Biological Availability; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hypolipidemic Agents; Kinetics; Male	1984
[Atherosclerosis treatment with etofibrate retard. New perspectives]. Fortschritte der Medizin, 1983, Aug-11, Volume: 101, Issue:30 Topics: Arteriosclerosis; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid	1983
Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products. Journal of pharmaceutical sciences, 1983, Volume: 72, Issue:11 Topics: Animals; Blood Proteins; Chromatography, High Pressure Liquid; Clofibrate; Clofibric Acid; Dogs; Erythrocytes; Humans; Hydrolysis; In Vitro Techniques; Plasma; Protein Binding; Ultrafiltration	1983
[Longterm therapy and etofibrate (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3 Topics: Anticholesteremic Agents; Blood Cell Count; Blood Glucose; Clofibrate; Clofibric Acid; Drug Administration Schedule; Drug Tolerance; Humans; Hyperlipoproteinemias; Triglycerides	1980
[Bezafibrate and delayed action etofibrate in hyperlipidemia]. Deutsche medizinische Wochenschrift (1946), 1983, Feb-25, Volume: 108, Issue:8 Topics: Bezafibrate; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Triglycerides	1983
Effects of etofibrate on platelet function: in vitro studies in human plasma. Thrombosis research, 1980, Aug-01, Volume: 19, Issue:3 Topics: Animals; Blood Platelets; Clofibrate; Clofibric Acid; Epoprostenol; Humans; Male; Malondialdehyde; Nicotinic Acids; Platelet Factor 3; Rats; Serotonin	1980
Predictions of stability in pharmaceutical preparations XIX: Stability evaluation and bioanalysis of clofibric acid esters by high-pressure liquid chromatography. Journal of pharmaceutical sciences, 1982, Volume: 71, Issue:1 Topics: Animals; Buffers; Chromatography, High Pressure Liquid; Clofibrate; Clofibric Acid; Dogs; Drug Stability; Humans; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Kinetics; Models, Chemical	1982
[Lowering lipids rapidly and permanently with etofibrate]. Medizinische Klinik, 1982, Jan-29, Volume: 77, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Clofibric Acid; Dextrothyroxine; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Liver; Nicotinic Acids; Sitosterols	1982
[Lipid lowering improved? Therapeutic progress by using biological mechanisms]. Die Medizinische Welt, 1982, Sep-10, Volume: 33, Issue:36 Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II	1982
[What is important in therapy of hyperlipoproteinemia. Lipo-Merz retard (etofibrate) lowers the atherogenic index]. Fortschritte der Medizin, 1982, Sep-16, Volume: 100, Issue:35 Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipoproteinemias	1982
[Stability of antilipidemic etofibrate and its metabolites towards gastrointestinal and blood hydrolases (author's transl)]. Arzneimittel-Forschung, 1980, Volume: 30, Issue:6 Topics: Biotransformation; Clofibrate; Clofibric Acid; Digestive System; Drug Stability; Esterases; Humans; Hydrolases; Hypolipidemic Agents; Kinetics	1980
[Etofibrate lowers the atherosclerosis index]. Medizinische Klinik, 1981, Mar-13, Volume: 76, Issue:6 Topics: Arteriosclerosis; Clofibrate; Clofibric Acid; Humans; Lipids	1981
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)]. Minerva medica, 1980, Feb-11, Volume: 71, Issue:4 Topics: Adult; Aged; Bile; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged	1980
The effect of etofibrate retard, bezafibrate and procetofen. Artery, 1980, Volume: 8, Issue:2 Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Middle Aged; Patient Compliance; Propionates; Triglycerides	1980
[Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate]. Fortschritte der Medizin, 1980, Dec-04, Volume: 98, Issue:45 Topics: Adult; Bezafibrate; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged	1980